Last reviewed · How we verify
NCT00077038
Brain Activity in Visual-Motor Behavior
trial in Healthy in 20 participants. Completed in 31 March 2007.
Quick facts
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 6 February 2004 |
| Estimated completion | 31 March 2007 |
| Sites | 1 location across United States |
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Who can join
20 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will examine how the brain works when people look at an object, follow a moving object with their eyes, and reach out their hand to an object. Different areas of the brain work together in reaching out a hand to an object. These areas are also important for concentrating on objects or following them with the eyes. This study will use magnetoencephalography (MEG) to observe more precisely how discrete parts of the brain work during these movements. MEG is a new technique for recording magnetic field changes produced by brain activity. Healthy normal volunteers 20 years of age and older who are right-handed and who have no history of brain or eye disease may be eligible for this study. Candidates will be screened with a medical history and brief physical examination. They will complete questionnaires for MEG screening and for determining handedness. Participants undergo MEG recording and magnetic resonance imaging (MRI). For MEG, the subject sits comfortably in front of a computer screen, and a cone containing magnetic field detectors is lowered onto the head. Electrodes are placed on both sides of the outer part of the eyelids and just above and below the left eye to monitor eye movement. During MEG, subjects perform the following tasks: 1. Eye fixation: A small white cross and a white ring appear on the center of the computer screen. Another white ring moves slowly around the screen in random fashion. Subjects keep their eyes fixed on the central cross and concentrate on the ring at the center, ignoring the moving ring. 2. Ocular tracking: The same cross and rings in task 1 appear on the screen, but in this task the subjects follow the moving ring with their eyes and ignore the cross and ring in the center. 3. Peripheral manual tracking task (right hand): In addition to the cross and rings in task 1, a small white disc-shaped cursor appears on the screen. Using their right hand, subjects use a joystick to move the cursor as precisely as possible to follow the moving ring, while keeping their eyes fixed on the central cross. 4. Peripheral manual tracking task (left hand): The same as task 3, except using the left hand. 5. Central manual tracking: The cross, rings, and joystick are the same as in task 3. Subjects move the cursor to follow the moving ring as precisely as possible, while following the moving ring with their eyes and ignoring the cross and ring in the center of the screen. Subjects practice each task before MEG recording starts. Then they perform each task twice in random order, with a 1- or 2-minute break between tasks. Subjects who do not have previous MRI images filed in NINDS's database undergo MRI scanning. MRI uses a strong magnetic field and radio waves to obtain images of body organs and tissues. The scanner is a metal cylinder surrounded by a strong magnetic field. Subjects lie still on a table that can slide in an out of the cylinder. They can communicate with the MRI staff at all times during the procedure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT00077038
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other National Institute of Neurological Disorders and Stroke (NINDS) trials
Trials by the same sponsor.
- NCT07137442 — Distinguishing Tics and Functional Tics Using Clinical Neurophysiological Techniques · recruiting
- NCT02522611 — Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain · Phase 1, PHASE2 · not yet recruiting
- NCT07511049 — Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study · Phase 2 · not yet recruiting
- NCT07416188 — Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma · Phase 1, PHASE2 · not yet recruiting
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT00077038 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute of Neurological Disorders and Stroke (NINDS)
- Last refreshed: 2 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00077038.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing